-
Buyer Связаться с продавцом
-
7 Записей
-
0 Фото
-
0 Видео
-
Female
-
Читают 0 человек
Недавние обновления
-
Why Stronger Antibodies Aren't Always Better: The Role of AI in Drug DevelopmentWhen scientists develop new medicines, finding a molecule that binds tightly to its intended target often feels like a major breakthrough. But in antibody drug development, stronger binding does not always translate into a better medicine. An antibody might recognize a disease-related protein extremely well yet struggle to remain stable during storage, form unwanted aggregates, or become too...0 Комментарии 0 Поделились 14 Просмотры 0 предпросмотрВойдите, чтобы отмечать, делиться и комментировать!
-
Why Is It So Hard for Medicines to Reach the Brain? How 3D Models Are Helping Scientists Find AnswersThe human brain is one of the most protected organs in the body. While this protection is essential for keeping harmful substances away, it also creates a major challenge for scientists developing treatments for neurological diseases. The main obstacle is the blood-brain barrier (BBB), a highly selective boundary that regulates which substances can move from the bloodstream into the brain. For...0 Комментарии 0 Поделились 11 Просмотры 0 предпросмотр
-
Why Bifidobacterium bifidum Matters for Gut Health and DigestionWhen people think about digestive health, they often focus on what they eat. But inside the human gut lives a complex community of microorganisms that also influences how our digestive system functions. Among these microorganisms, Bifidobacterium bifidum has attracted scientific interest for its ability to interact with dietary carbohydrates, intestinal mucus, and other members of the gut...0 Комментарии 0 Поделились 18 Просмотры 0 предпросмотр
-
Why Do Promising Drugs Fail? The Science Behind Drug DevelopmentEvery year, scientists discover compounds that show remarkable potential in laboratory experiments. Some can destroy cancer cells, block harmful enzymes, or interfere with disease-causing microorganisms. Yet many promising compounds never become approved medicines. Why does something that works in a laboratory sometimes fail when tested in a living organism? The answer often lies in what...0 Комментарии 0 Поделились 13 Просмотры 0 предпросмотр
-
Why Targeting Cancer Cells Is Only Half the Challenge in Precision MedicinePrecision cancer treatment promises a more targeted approach to fighting disease. But finding the right cancer cells is only the beginning. What happens after a drug reaches its target may be just as important. Imagine a delivery service that knows exactly where a package needs to go. Finding the correct address is essential, but the delivery is not complete until the package reaches its...0 Комментарии 0 Поделились 11 Просмотры 0 предпросмотр
-
Beyond Potency: Why Early ADME Screening Matters in Oncology Drug DiscoveryA small molecule shows strong activity against a cancer-related target. Follow-up experiments confirm the initial result, and the chemistry team begins developing related compounds. Yet one question remains: can the molecule achieve the exposure needed to make that activity meaningful? Potency provides only part of the answer. Researchers also need to understand how a compound crosses...0 Комментарии 0 Поделились 17 Просмотры 0 предпросмотр
-
Single-Cell or Single-Nucleus RNA Sequencing? Start with Your SampleA frozen tissue specimen, a fresh cell suspension, and a fixed sample may all hold valuable information about cellular diversity. However, they do not necessarily belong in the same transcriptomics workflow. Before planning a single-cell study, researchers need to consider how their samples were collected, which cell populations matter most, and what biological questions the experiment should...0 Комментарии 0 Поделились 10 Просмотры 0 предпросмотр
Больше